Literature DB >> 22138563

Bridging solubility between drug discovery and development.

Li Di1, Paul V Fish, Takashi Mano.   

Abstract

Solubility has a crucial role in the success of a drug candidate. Compounds with low solubility not only cause problems for in vitro and in vivo assays, but also add significant burdens to drug development. Drug discovery and drug development often have different solubility screening requirements and methodologies have been developed to meet the needs of these different stages.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 22138563     DOI: 10.1016/j.drudis.2011.11.007

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  53 in total

1.  Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos.

Authors:  Golara Golbaghi; Mohammad Mehdi Haghdoost; Debbie Yancu; Yossef López de Los Santos; Nicolas Doucet; Shunmoogum A Patten; J Thomas Sanderson; Annie Castonguay
Journal:  Organometallics       Date:  2019-01-31       Impact factor: 3.876

2.  Do Zebrafish Obey Lipinski Rules?

Authors:  Keith Long; Stephen J Kostman; Christian Fernandez; James C Burnett; Donna M Huryn
Journal:  ACS Med Chem Lett       Date:  2019-04-24       Impact factor: 4.345

3.  Tailoring supersaturation from amorphous solid dispersions.

Authors:  Na Li; Lynne S Taylor
Journal:  J Control Release       Date:  2018-04-11       Impact factor: 9.776

4.  Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.

Authors:  Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-09-27       Impact factor: 4.200

5.  Interpreting physicochemical experimental data sets.

Authors:  Nicola Colclough; Mark C Wenlock
Journal:  J Comput Aided Mol Des       Date:  2015-06-09       Impact factor: 3.686

6.  An uncharged oxetanyl sulfoxide as a covalent modifier for improving aqueous solubility.

Authors:  Erin M Skoda; Joshua R Sacher; Mustafa Z Kazancioglu; Jaideep Saha; Peter Wipf
Journal:  ACS Med Chem Lett       Date:  2014-06-27       Impact factor: 4.345

7.  Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-α/SPD304 Study.

Authors:  Christos P Papaneophytou; Anthi K Mettou; Vagelis Rinotas; Eleni Douni; George A Kontopidis
Journal:  ACS Med Chem Lett       Date:  2012-11-29       Impact factor: 4.345

8.  Ahp-Cyclodepsipeptide Inhibitors of Elastase: Lyngbyastatin 7 Stability, Scalable Synthesis, and Focused Library Analysis.

Authors:  Danmeng Luo; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2020-03-04       Impact factor: 4.345

Review 9.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

10.  Stereochemistry Balances Cell Permeability and Solubility in the Naturally Derived Phepropeptin Cyclic Peptides.

Authors:  Joshua Schwochert; Yongtong Lao; Cameron R Pye; Matthew R Naylor; Prashant V Desai; Isabel C Gonzalez Valcarcel; Jaclyn A Barrett; Geri Sawada; Maria-Jesus Blanco; R Scott Lokey
Journal:  ACS Med Chem Lett       Date:  2016-06-06       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.